Gossamer Bio, Inc.

US$9.77As of Sun 8 Nov 2026, 12:00 UTC
NASDAQ:GOSSHealthcare
Country USA
PE (Fwd) •••
TSR 8Y CAGR (49.04%)
Div yield —
ROE —
Biotechnology
Beta (5Y) 2.27
PE TTM —
TSR TTM (95.02%)
Mkt cap US$59.76M
ROIC (192.94%)
SE Grade™
Value
Quality
Moat
Consensus
Reference
$11
13.99%
(88.61%)
Sell 1|7|7|0|2
4Q25
1Q26
2Q26
3Q26
Earnings per share$
0.13
0.14
0.16
0.17
6.91%
19.65%
31.07%
28.74%
Revenue$M
3.013
2.969
2.938
3.027
15.27%
9.70%
2.77%
1.08%
Peers (US$59.76M)
Cap (US$)
PE
61.70M
0.569x
59.98M
8.061x
59.75M
139.8x
Capital
TTM
5Y
10Y
Leveragex
0.396
6.538
4.557
EBIT/Intx
5.901
0.197
0.239
Own earn%
667.77
(0.79)
3.88
Sh yield%
28.67
32.26
31.11
Owners
Insiders/Inst%
5.28
39.27
Short interest%
3.80
SBC / revenue%
3.95
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
14
Op margin range%
13–17
$1 testx
−0.1
Incr. ROIC%
4